Sitemap - 2025 - Cardiology Trial’s Substack

Summary and discussion of Carvedilol Prospective Randomized Cumulative Survival Study, Val-HeFT, CHARM-Added and CIBIS-II

Review of the CIBIS-II Trial

Review of the CHARM-Added trial

Review of the Val-HeFT trial

Review of the Carvedilol Prospective Randomized Cumulative Survival Study

Summary and discussion of U.S. Carvedilol Heart Failure, DIG, RALES, MERIT-HF, and ATLAS

Review of the ATLAS trial

Review of the MERIT-HF trial

Review of the RALES trial

Review of the DIG trial

Review of the U.S. Carvedilol Heart Failure Study

Summary and discussion of V-HEFT II and SOLVD

Review of the SOLVD trials

Review of the V-HEFT II trial

Summary and discussion of V-HEFT I and CONSENSUS

Review of the CONSENSUS trial

Review of the V-HEFT I Trial

Summary of procedural interventions in acute coronary syndrome

Review of the CULPRIT-SHOCK Trial

Summary and discussion of MOSCA-FRAIL and SENIOR-RITA

Review of the SENIOR-RITA trial

Review of the MOSCA-FRAIL trial

Summary and discussion of TACTICS-TIMI 18, RITA 3 and ICTUS

Review of the ICTUS trial

Review of the RITA 3 trial

Review of the TACTICS-TIMI 18 trial

Summary and discussion of PRAMI, COMPLETE and FULL REVASC

Review of the FULL REVASC trial

Review of the COMPLETE trial

Review of the PRAMI Trial

Summary and discussion of TAPAS and TASTE

Summary and discussion of trials of fibrinolysis vs invasive strategy in STEMI

Review of the TASTE trial

Summary and discussion of OAT

Review of the TAPAS trial

Review of the STREAM trial

Summary of non-pharmacological interventions in stable coronary artery disease

Summary and discussion of FAME and RIVAL

Review of the OAT Trial

Review of the DANAMI-2 trial

Review of the Primary Angioplasty in Myocardial Infarction Study Group trial

Review of the RIVAL trial

Review of the FAME trial

Summary and discussion of NORSTENT

Review of the NORSTENT trial